IDEAYA Biosciences, Inc. (IDYA) stock
IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/309% above fair value
$31.83+0.34 (+1.08%)
Close on Nov 13, 2026Market cap $3.07BP/E –Yield –
IDEAYA Biosciences statistics
76 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 16, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 2.56
- 2.22
Enterprise valuationIndustry
- EV / Sales
- 9.58
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 2.46%
- 10.8%
- Shares Change (QoQ)
- 9.70%
- 0.50%
- Float
- 96M
- 49M
- Shares Held by Insiders
- 0.83%
- 11.7%
- Shares Held by Institutions
- 106.0%
- 56.4%
Short sellingIndustry
- Short Interest
- 8M
- –
- Short Interest Change
- -9.28%
- -0.80%
- Short % of Float
- 8.61%
- 9.01%
- Short % of Shares Outstanding
- 8.54%
- 6.30%
- Days to Cover
- 8.87
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $42.68
- –
- 52-Week Low
- $26.81
- –
- 20-Day Moving Average
- $32.88
- –
- 50-Day Moving Average
- $35.47
- –
- 200-Day Moving Average
- $33.85
- –
- Average True Range (14)
- $1.46
- –
- Price Change (1 Week)
- 1.89%
- -1.15%
- Price Change (1 Month)
- -5.97%
- -4.87%
- Price Change (3 Months)
- -12.9%
- -21.0%
- Price Change (6 Months)
- 12.8%
- -20.6%
- Price Change (YTD)
- -7.93%
- -23.6%
- Price Change (1 Year)
- -0.38%
- -22.4%
- Price Change (3 Years)
- 6.81%
- -29.5%
- Price Change (5 Years)
- 38.2%
- -77.9%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 849,702
- –
- Relative Volume
- 0.91
- 0.70
- Relative Strength Index (14)
- 42.4
- 43.4
- Volatility (1 Year)
- 44.9%
- 80.1%
- Beta (5 Years)
- 0.78
- 1.07
MarginsIndustry
- EBITDA Margin
- -91.5%
- -27.7%
- FCF Margin
- -48.6%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- -16.2%
- -49.9%
- Return on Assets (ROA)
- -14.9%
- -40.6%
- Return on Invested Capital (ROIC)
- -51.9%
- -32.9%
- Return on Capital Employed (ROCE)
- -17.7%
- -37.9%
Financial positionIndustry
- Current Ratio
- 10.45
- 3.30
- Quick Ratio
- 10.03
- 2.39
GrowthIndustry
- Revenue Growth (3Y CAGR)
- 62.5%
- 2.25%
- Revenue Growth (5Y CAGR)
- 62.1%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.20
- 0.40
- Revenue Per Employee
- $1.61M
- $429.29K
- Profits Per Employee
- -$1.21M
- -$689.41K
- Employee Count
- 145
- 74
- WACC
- 8.98%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $828.96M
- $17.76M
- Net Cash Per Share
- $8.59
- $0.80
- Equity (Book Value)
- $1.20B
- $53.89M
- Book Value Per Share
- $12.43
- $1.50
- Tangible Book Value
- $1.20B
- $27.13M
- Working Capital
- $781.35M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$2.21M
- -$1.00M
- FCF Per Share
- -$1.18
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -5.70%
- -21.8%
- FCF Yield
- -3.71%
- -9.44%
Taxes and interestIndustry
- Income Tax
- $0
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- 15.97
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | IDYA | S&P 500 | Difference | IDYA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -7.1% | -3.0% | −4.1 pts | ||
| 3 months | -13.2% | -2.8% | −10.4 pts | ||
| Year to date | -7.9% | +11.5% | −19.4 pts | ||
| 1 year | +0.0% | +13.5% | −13.4 pts | ||
| 3 years | +9.0% | +77.7% | −68.7 pts | +2.9% | +21.1% |
| 5 years | +38.2% | +72.6% | −34.4 pts | +6.7% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
8M IDYA shares were sold short on Oct 30, 2026, down 9.3% from the previous report, or 8.61% of the shares available to trade. At recent volumes it would take 8.9 days to buy them back. Over the last 20 sessions, 53.4% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 8,236,480 | -9.3% | 928,512 | 8.9 |
| Oct 15, 2026 | 9,079,434 | -1.1% | 754,634 | 12.0 |
| Sep 30, 2026 | 9,183,217 | -7.5% | 1,088,895 | 8.4 |
| Sep 15, 2026 | 9,931,622 | -1.7% | 575,248 | 17.3 |
| Aug 31, 2026 | 10,103,757 | -2.8% | 827,360 | 12.2 |
| Aug 14, 2026 | 10,398,078 | +2.8% | 629,939 | 16.5 |
| Jul 31, 2026 | 10,113,206 | +5.6% | 766,531 | 13.2 |
| Jul 15, 2026 | 9,573,580 | -7.4% | 1,111,934 | 8.6 |
| Jun 30, 2026 | 10,334,969 | -2.8% | 1,701,073 | 6.1 |
| Jun 15, 2026 | 10,629,114 | -6.3% | 1,411,672 | 7.5 |
| May 29, 2026 | 11,338,312 | -3.1% | 693,874 | 16.3 |
| May 15, 2026 | 11,704,298 | -0.0% | 838,482 | 14.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?